Treatment recommendation for advanced skin cancer Advanced (unresectable or metastatic) melanoma. 18 Feb 2016 NICE final guidance recommending nivolumab as monotherapy for treating advanced skin cancer. Nivolumab called Opdivo, and manufactured by Bristol Myers Squibb is to be made available on the NHS as a treatment option for patients with advanced unresectable or metastatic melanoma.…
uk: New drug availability
Various chronic diseases New drugs available on the NHS for chronic lymphocytic leukaemia. NICE has issued two pieces of final guidance recommending obinutuzumab …. more (Gazyvaro, Roche) and ofatumumab .…more (Arzerra, Novartis), which are each given in combination with chlorambucil, for people with previously untreated chronic lymphocytic leukaemia if treatments containing fludarabine or bendamustine are…